Clinical Trials Browser

Small Cell Lung Carcinoma × famitinib × Clear all

NCT06332950 2024-03-27

Safety and Efficacy of Adebrelimab Plus Irinotecan Liposome (II) With or Without Famitinib in ES-SCLC Pre-treated With Immunotherapy

Phase 1/2 Not yet recruiting

Small Cell Lung Carcinoma

NCT06306560 2024-03-12

A Study of Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC.

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma